DermaTherapy Skin Protection System

• Treatment of pressure ulcers cost the NHS 1.4 to 2.1 Billion GBP a year or 14% of total expenditure.

• 20% of patents in acute care develop a pressure ulcer.

• 20 to 24% of beds are occupied each day by pressure ulcer patients with 60 to 80% of those being hospital acquired.

• Globally pressure ulcers affect 15% of patients across a variety of healthcare settings.

• The cost of treating pressure ulcers is 3.6 times the cost of preventing them,

• DermaTherapy is a FDA approved Class I Medical Device and has been granted U.S. Patent Protection.

• It has been granted clearance by the European Economic Areas as a CE-marked medical device for the prevention and treatment of pressure ulcers.

• Designed by the Precision Fabrics Group (PFG) a world class developer and manufacturer of advanced high performance materials for aerospace, military, medical, industrial, protective apparel and more.

• PFG used the latest developments and advances in fabric science to develop the “next generation” surface for use in the DermaTherapy Skin Protection System.

• This advanced skin protection surface incorporated the use of uniquely structured fibers and chemical coatings that create a cleaner, drier and smoother “patient microclimate”. (A key condition in the prevention and treatment of pressure ulcers.)

Prevention of Pressure Ulcers

The Causes of Pressure Ulcers• Pressure: the perpendicular force

that compresses tissues.• Shear: the force parallel to the skin

surface.• Friction: the adherent force

resisting shearing movement of the skin.

• Patient’s Microclimate: the immediate environment surrounding a patient..

DermaTherapy Skin Protection System utilizes the latest advances in material science to create a silk-like fabric that significantly reduces the amount of

friction and shear that a patient would normally experience on a traditional bedding surface.

DermaTherapy Polyester/Cotton

Friction and Shear

DermaTherapyCoefficient of Friction =

0.30 dry 0.22 wet

Poly/CottonCoefficient of Friction =

0.28 dry 0.42 wet

Unlaundered Laundered 175X

• Heat and Moisture: – Moisture from perspiration or incontinence

create maceration of the skin and weakens the underlying tissue.

– Macerated skin is more susceptible to the effects of pressure , shear and friction.

– Skin hydration (moisture) promotes adhesion of the skin to support surfaces and increases shear, easy sloughing and ulceration.

– Keeping the patient dry is now recognized as a critical element in both the prevention and treatment of pressure ulcers

• DermaTherapy fabrics immediately wick moisture away from the body and dry very quickly. Water loss from the fabric is facilitated through rapid wicking and evaporation.

• This helps to remove heat from the body and reduces perspiration

• Helps maintain the body’s water balance to more effectively control skin temperature and moisture

DermaTherapy helps managethe patient micro-environment

Moisture

Cotton Blend

DermaTherapy

0 2 4 6 8 10 12 14 16 18 20

Wicking Comparison

Wicking Rate (mm/min)

0 15 30 45 60 750%

20%40%60%80%

100%Drying Comparison

DermaTherapy Cotton Blend

Minutes

Similar to Technology Used in the Most Advanced Outdoor Garments DermaTherapy Wicks & Dries Quickly

Keeping the Patient Drier Than Current Patient Surfaces

Percent Reduction (%) of Bacteria on Cotton

Staphylococcus aureusMRSA

Enterococcus faecalis

Hospital Top SheetWoven cotton blend

No reduction1,865 % growth

No reduction5,015 % growth

Hospital Fitted Bottom SheetKnitted cotton blend

No reduction5,560 % growth

No reduction16,389 % growth

Bacteria

Percent Reduction of Bacteria (%)

Staphylococcus aureus

Staphylococcus epidermidis

Escherichia coli

Klebsiella pneumoniae

P/C Laundered 0X 0% 0% 0% 0%

DT Laundered 0X >99.999% >99.999% >99.999% >99.999%

DT Laundered 30X >99.999% 99.991% >99.999% >99.999%

DT Laundered 100X 99.995% 99.990% 98.050% 91.088%

DermaTherapy Controls Bacteria

DermaTherapy Surfaces Incorporate the Highly Effective and Proven Safe AEGIS MicrobeShield Antibacterial Agent

Microbiological Analysis: AATCC 100

Sheets0

2

4

6

8

10

12

14

0.4 0.2

Clean/Laundered

Control DermaTherapy

CFUs

per

cm

2

Sheets0

5,000

10,000

15,000

20,000

25,000

30,000

35,000

40,000 37,402

1,309

Used 24 - 48 Hours

Control DermaTherapy

CFUs

per

cm

2

Bioburden Analysis in LTC SettingAverage CFUs of Bacteria/cm2 per Item

Hospital Gown

Hospital Bottom Sheet

Hospital Top Sheet

DermaTherapy

33,75532,333

15,933

540

Number of Airborne Particles

Virtually Lint Free DermaTherapy does not generate

airborne particles that contribute to higher Bioburden levels on bedding and gowns thus lowering the risk potential for cross-contamination

DermaTherapy Skin Protection System

• The DermaTherapy System is an integral part of any medical facility’s protocol for the prevention and treatment of pressure ulcers as well as many other skin conditions.

• It augments and works in conjunction with established procedures and treatment regiments.

• It helps manage a patient’s microclimate providing the patient a drier and more comfortable environment while significantly reducing friction and shear, all major elements in the prevention of pressure ulcers.

• It is antimicrobial and lint free in order to aid in the prevention of wound infections contamination.

• It is highly effective and extremely cost effective in preventing pressure ulcers and in most cases reduces or eliminates the need for more costly wound care products and specialized beds.

• The individual components of the DermaTherapy Skin Protection System are sold separately in order to allow the clinician maximum flexibility and choice in the treatment of their patients.

• This also allows staff to prescribe the most effective treatment for each patient by using only the components that are needed. In most instances for non-incontinent patients only a Skin Protection Fitted Surface and a Head Surface is all that is needed to prevent and help heal many pressure ulcers. The DermaTherapy Skin Repositioning/Incontinence Surface is also available to replace existing repositioning devices.

• This “patient specific” approach allows DermaTherapy Skin Protection Surfaces to be easily incorporated into your existing protocols.

• Standard Skin Protection System (Recommended) • (1) Fitted or Flat Surface• (1) Head Surface• (1) Repositioning/Incontinence Surface

• Maximum Skin Protection System • (1) Patient Top Cover Surface• (1) Patient Gown Surface

Daily Patient Requirement

*Total amounts required for an ongoing program are based on individual institutional protocols, patient needs and cleaning schedules.

• The components of the DermaTherapy Skin Protection System are designed in the shape of traditional bedding , positioning/incontinence devices and gowns so that the items can easily be incorporate into existing clinical protocols and standard laundry cleaning procedures.

• DermaTherapy Skin Protection components design minimizes staff training and with a few new minor handling techniques the product is readily accepted by the medical facility’s staff.

• DermaTherapy’s Fitted and Flat Surfaces can be put over the top of the current mattress sheet but most institutions find it more convenient to do away the use of their existing bed cover and simply replace it with the DermaTherapy Surface (additional cost savings).

Design

Results

• DermaTherapy has recently been introduced to US medical market and is in use in several major hospitals and long term care facilities in the USA with over 1,000,000 patient days of use.

• Patient experience, as well as documented and published trials of the DermaTherapy Skin Protection System have demonstrated that it has reduced or prevented pressure ulcers on an average up to 80%.

• The DermaTherapy Skin Protection System is gaining momentum and support by the medical community as the “new standard of care” in the prevention of pressure ulcers.

Patient Care

Published Trial Results

Ostomy Wound Management Publications

Durham, VA LTCDecember 2012

Wesley Long HospitalApril 2013

Moses Cone HospitalOctober 2012

Durham VA Medical Center

November 19, 2010 – May 27, 20116 months, 9 days – 46 LTC patients

RTC Trial with Patient Consent

Controlsn=20

DermaTherapyn=26 % Change

Development of All Wounds 20 6 - 70 %

Development of Stage 2+ PUs 16 4 - 75 %

Twersky J, Montgomery T, Sloane R, Weiner M, Doyle S, Mathur K, Francis M, Schmader K. A Randomized, Controlled Study to Assess the Effect of Silk-like Textiles and High-absorbency Adult Incontinence Briefs

on Pressure Ulcer Prevention. J Ostomy Wound Management 2012;58(12):18–24.

Total Pressure Ulcers DevelopedDurham VA Medical Center - LTC

Health Economics

a) DermaTherapy Skin Protection components are an excellent addition to any medical facility’s infection control program. Its AEGIS MicrobeShield Antibacterial agent is safe and highly effective at killing several different bacteria type.

b) It has been approved by the FDA as effective treatment for mild atopic Dermatitis.

c) DermaTherapy Skin Protection components are also an effective allergen barrier against dust mites and several other allergens.

d) The Skin Protection System is often prescribed for menopausal women for a more comfortable sleep while experiencing hot flashes and night sweets.

1) Reduces Patient Risks

a) DermaTherapy Skin Protection System requires no additional nursing time or clinical expertize. While its surfaces are constructed of highly advanced fabrics, it is specifically designed to be easily applied and cleaned by those charged with managing laundry.

b) DermaTherapy is designed to prevent pressure ulcers for all parts of the body that it comes in contact with and is not site specific thus reducing nursing time associated with site specific treatments such as pads, dressings, etc.

c) Care givers do not need to spend time cutting, shaping, applying and washing site specific pads or dressings.

d) Nursing staff and patients generally do not need to apply lotions and ointments in conjunction with DermaTherapy in order to prevent pressure ulcers.

2) Reduces Nursing Time

a) DermaTherapy is a economical “multi-site” application for the prevention of pressure ulcers and does not require “costly single site” pads and dressings.

b) Its components are not patient specific and can be used by other patients following proper cleaning by the laundry.

c) DermaTherapy Skin Protection components are designed to far out last conventional materials such as gel pads since they can be washed hundreds of times by the laundry.

3) Reduces Material Cost

Daily Cost Gel/FoamPads

Wound CareDressings

DermaTherapy

Head

Shoulder (2)

Sacrum

Hips (2)

Heals (2)

Total Cost

Pressure Ulcer Prevention for At Risk Patients

a) DermaTherapy reduces the amount of stock that wards keep in preventing pressure ulcers.

b) It often eliminates the need for many of these prevention devices such as special foot ware, special gel pads, etc.

4) Reduces Complexity and Inventory

a) While DermaTherapy Skin Protection System can be easily incorporated into your existing protocols and equipment such as pressure relieving beds, it has proven to be highly effective at preventing pressure ulcers with use on your standard hospital bed.

5) Reduces Capital Equipment Cost

a) Due to significant patient benefits and the economic advantages of DermaTherapy, hospitals and long term care facilities often take a “whole facility approach”.

b) They replace all of their existing traditional bed linen with the DermaTherapy Skin Protection System since it far outlast bed linen and can generally save the laundry up to 35% in laundry cost, as well as being much more environmentally friendly.

c) DermaTherapy Skin Protection components have an anti-stain treatment that make them virtually stain resistant and reduces the amount of linen thrown away.

6) Reduces Laundry Cost

a) A trial date is agreed and set.b) Protocols and trial procedures are discussed. c) Information and trial support documents used in previous trials will be

provided to the institution but trial protocols are entirely at the discretion of the medical institution.

d) Agree to the number of components required for the trial.e) DermaTherapy Skin Protection System materials will be provided to the

institution for a 60 day trial period free of charge.

60 Day Trial Period

At the end of the trial period all components are returned or purchased by the facility.